Development of New Technologies and Bioengineering Solutions for the Advancement of Cell Replacement Therapies for Type 1 Diabetes
Published Date
Agency
CFDA
93.847
Contact Information
National Institutes of Health Grants Information, 301-435-0714; GrantsInfo@nih.gov
Deadline
Department
Eligiblity
Small businesses
More Information
Program Area
Programe Purpose
To support research that develops cell replacement therapies for type 1 diabetes patients
